Bonum Therapeutics

0 followers


Bonum Therapeutics is creating a technology platform that can be used to treat a wide range of diseases, including cancer which is the company’s primary therapeutic area of focus—as well as metabolic diseases, immunology, and pain management.

Employees

11-50

Links

Org chart

John Mulligan, Ph.D.
Founder and CEO

John Mulligan, Ph.D.

Collapse
David Bienvenue
Senior Director, Protein Sciences
Cindy Lai Yee
Vice President Of Preclinical Development